RAPT Therapeutics, Inc.RAPTNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank37
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P37
Within normal range
vs 2Y Ago
-0.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q3 2025-10.14%
Q2 202578.44%
Q1 2025-402.56%
Q4 202440.82%
Q3 202437.35%
Q2 2024-3.55%
Q1 20242.27%
Q4 2023-26.75%
Q3 202324.42%
Q2 2023-50.00%
Q1 202315.45%
Q4 2022-32.90%
Q3 2022-9.32%
Q2 2022-0.22%
Q1 202225.38%
Q4 2021-67.41%
Q3 20219.95%
Q2 20211.11%
Q1 20219.03%
Q4 2020-54.18%
Q3 2020-56.82%
Q2 202027.32%
Q1 2020-54.79%
Q4 201953.23%
Q3 2019-30.21%
Q2 2019-3.62%
Q1 201916.68%
Q4 2018-12.49%
Q3 2018-22.65%
Q2 20182.22%
Q1 20180.00%